Other
Antithrombotic
0
Pipeline Programs↗
11
Active Trials↗
0
Companies Involved↗
Antithrombotic is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
30
clinical trials
Completed12 · 40%
Recruiting8 · 27%
Unknown status6 · 20%
Not yet recruiting2 · 7%
Active, not recruiting1 · 3%
Terminated1 · 3%
Clinical Trials
Trial Activity
30 trials
REGistry of Long-term AnTithrombotic TherApy-2
Recruiting·National Medical Research Center for Cardiology, Ministry of Health of Russian Federation·N/A·NCT04347187·2,000 enrolled
REGistry of Long-term AnTithrombotic TherApy-1
Recruiting·National Medical Research Center for Cardiology, Ministry of Health of Russian Federation·N/A·NCT04347200·2,000 enrolled
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant
Recruiting·—·Phase 4·NCT07007143·1,032 enrolled
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant
Recruiting·—·Phase 4·NCT06901466·880 enrolled
Antithrombotic Therapy at the End of Life: The PEACE Study
Not yet recruiting·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·N/A·NCT07338071·410 enrolled
Partial Thromboplastin Time During the First 24 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin (UFH)
Completed·—·N/A·NCT01070875·53 enrolled
Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI
Completed·CCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec·Phase 4·NCT02640794·222 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)